Menu
Back to Journals » Transplant Research and Risk Management » Volume 2
Transplant Research and Risk Management
ISSN: 1179-1616
- View all (89)
- Volume 15, 2023 (1)
- Volume 14, 2022 (6)
- Volume 13, 2021 (3)
- Volume 12, 2020 (5)
- Volume 11, 2019 (8)
- Volume 10, 2018 (1)
- Volume 9, 2017 (7)
- Volume 8, 2016 (5)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5 , 2013 (3)
- Volume 4, 2012 (5)
- Volume 3, 2011 (10)
- Volume 2, 2010 (13)
- Volume 1, 2009 (2)
Archive: Volume 2, 2010
Ethical issues in kidney transplantation – reflections from Nigeria
Joseph Olusesan Fadare, Babatunde L Salako
Transplant Research and Risk Management 2010, 2:87-91
Published Date: 19 November 2010
Delayed hyperacute rejection in a patient who developed clostridium difficile infection after ABO-incompatible kidney transplantation
Gerald S Lipshutz, Elaine F Reed, Phuong-Chi Pham, et al
Transplant Research and Risk Management 2010, 2:81-85
Published Date: 8 November 2010
Assessing the safety and quality of ward-based renal transplant biopsies
Kenneth Wu, Bindhu Musunuru, Chera Arunachalam, et al
Transplant Research and Risk Management 2010, 2:77-79
Published Date: 7 October 2010
Eleven years of management of children with intestinal failure and not candidates for intestinal transplantation
MI Spagnuolo, MP Cicalese, E Bruzzese, et al.
Transplant Research and Risk Management 2010, 2:71-75
Published Date: 1 September 2010
Role of tacrolimus prolonged release in the prevention of allograft rejection
Peter Abrams, Abhinav Humar, Henkie P Tan
Transplant Research and Risk Management 2010, 2:65-70
Published Date: 9 August 2010
Knowledge and level of awareness of renal transplantation among medical students in Nigeria
Augustine O Takure, Sylvester O Alikah, Vincent C Onuora
Transplant Research and Risk Management 2010, 2:59-64
Published Date: 22 July 2010
Clinical use of plerixafor in combination with granulocyte-colony stimulating factor in hematopoietic stem cell transplantation
Cedar J Fowler, Richard T Maziarz
Transplant Research and Risk Management 2010, 2:47-58
Published Date: 11 May 2010
Liver transplantation in Egypt from West to East
Galal H El-Gazzaz, Azza H El-Elemi
Transplant Research and Risk Management 2010, 2:41-46
Published Date: 7 April 2010
Valganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplantation
Erin Wade Ticehurst, Jennifer Trofe-Clark, Emily Blumberg, et al
Transplant Research and Risk Management 2010, 2:29-39
Published Date: 30 March 2010
Moving towards implementation of a clinical ethics consultation program in Egyptian liver transplant units
A H El-Elemi, G H El-Gazzaz
Transplant Research and Risk Management 2010, 2:23-27
Published Date: 16 March 2010
Low antigenicity of hematopoietic progenitor cells derived from human ES cells
Eun-Mi Kim, Nicholas Zavazava
Transplant Research and Risk Management 2010, 2:15-22
Published Date: 3 February 2010
Critical appraisal on the use of everolimus in renal transplantation as an immunosuppressant to prevent organ transplant rejection
Fernando Giron, Yenny Baez
Transplant Research and Risk Management 2010, 2:11-14
Published Date: 21 January 2010
Optimizing use of basiliximab in liver transplantation
Carlo B Ramirez, Adam Bozdin, Adam Frank, et al
Transplant Research and Risk Management 2010, 2:1-10
Published Date: 6 January 2010